abstract |
Disclosed herein is the use of SLURP-1 for the treatment or prevention of neurological disorders,and for the treatment or prevention of skin pathologies.The invention further discloses the use of SLURP-1 for the modulation of acetylcholine receptor activity.Antibodies generated against SLURP-1 and related proteins are also disclosed. |